CRAWFORD & COMPANY |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.6 EUR | -1.30% |
|
-1.91% | 0.00% |
| 05-23 | Barrington Raises Price Target on Crawford & Company to $12 From $11, Maintains Outperform Rating | MT |
| 05-10 | Crawford & Company Declares Quarterly Dividend, Payable on June 7, 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Its low valuation, with P/E ratio at 10.12 and 6.64 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Multiline Insurance & Brokers
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| 0.00% | 415M | - | ||
| +16.50% | 110B | C+ | ||
| +7.05% | 108B | B- | ||
| +12.01% | 105B | B | ||
| +9.78% | 78.14B | C+ | ||
| +28.81% | 30.62B | A- | ||
| +14.93% | 20.49B | A- | ||
| -0.65% | 12.09B | B- | ||
| +8.74% | 10.9B | A- | ||
| +25.83% | 10.52B | A- |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CRD.B Stock
- CWK Stock
- Ratings Crawford & Company
